Q: What is the size of the flavonoids market in 2021?

The Flavonoids market is estimated to be valued US$ 515.92 million in 2021.

Q: What is the projected CAGR at which the flavonoids market is expected to grow?

The Flavonoids market is expected to grow at a CAGR of 3.9% (2023-2032).

Q: List the segments encompassed in this report on the flavonoids market?

Market.US has segmented the Global Flavonoids Market Value (US$ Mn) Analysis by Region, 2022 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By product, market has been segmented into anthocyanin, flavones, anthoxanthins, and other products, By application, market has been segmented into functional beverages, functional food, dietary supplements, and other applications.

Q: List the key industry players of the flavonoids market?

Cayman Chemical Company, Quercegen Pharmaceuticals, Foodchem International Corporation, INDOFINE Chemical Company, Inc., Extrasynthese, Toroma organics Ltd, Pharmachem Laboratories Inc., Organic Herb Inc., Other Key Players are the key vendors in the flavonoids market.

Q: Which region is more appealing for vendors employed in the Flavonoids market?

North America is expected to account for the highest revenue share of 35%. Therefore, North America’s flavonoids industry is expected to garner significant business opportunities over the forecast period.

Q: Name the key areas of business for Flavonoids?

Key Markets should be The US, Mexico, Canada, Germany, UK, France, Italy, Spain, China, Japan, India, Brazil, etc. are key areas of operation for the flavonoids market.

Q: Which segment accounts for the greatest market share in the Flavonoids industry?

Concerning the flavonoids industry, vendors can expect to leverage greater prospective business opportunities through the flavones segment, as this area of interest accounts for the largest market share

Global Flavonoids Market By Product (Anthocyanins, Flavones, Anthoxanthins, and Other Products), By Application (Functional Beverages, Functional Food, Dietary supplements, and Other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Published date: Oct 2021
Report ID: 13976
Number of Pages: 215
Format:

- 1. Flavonoids Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Flavonoids Market Overview
  - 3.1. Flavonoids Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Manufacturer Intensity Map
- 4. Global Flavonoids Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Flavonoids Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Hesperidin
  - 4.4. Daidzein
  - 4.5. Catechin
  - 4.6. Genistein
  - 4.7. Others
- 5. Global Flavonoids Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Flavonoids Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Pharmaceutical
  - 5.4. Food & Beverages
  - 5.5. Dietary Supplements
  - 5.6. Feed Additives
  - 5.7. Others
- 6. Global Flavonoids Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Flavonoids Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2.1. Europe
    6.2.1. Europe Flavonoids Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Flavonoids Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia
  - 6.4. Latin America
    6.4.1. Latin America Flavonoids Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Flavonoids Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Flavonoids Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Zhejiang Conler Pharmaceutical
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. Chengdu Okay
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. Sichuan Deebio Pharmaceutical
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. Hunan Kang Biotech
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. Sichuan Xieli Pharmaceutical
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
  - 7.8. Shaanxi Huifeng Pharmaceutical
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
  - 7.9. SANREN Bio-Technology
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
  - 7.10. Chengdu Shuxi Pharmaceutical
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
  - 7.11. Hunan Yuantong Pharmaceutical
    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments
  - 7.12. Chengdu Yazhong Bio-pharmaceutical
    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments
  - 7.13. Chengdu Runde Pharmaceutical
    7.13.1. Company Overview
    7.13.2. Financial Highlights
    7.13.3. Product Portfolio
    7.13.4. SWOT Analysis
    7.13.5. Key Strategies and Developments
  - 7.14. Quzhou Tiansheng Plant Extract
    7.14.1. Company Overview
    7.14.2. Financial Highlights
    7.14.3. Product Portfolio
    7.14.4. SWOT Analysis
    7.14.5. Key Strategies and Developments
  - 7.15. Chengdu Hawk Bio-Engineering
    7.15.1. Company Overview
    7.15.2. Financial Highlights
    7.15.3. Product Portfolio
    7.15.4. SWOT Analysis
    7.15.5. Key Strategies and Developments
  - 7.16. Chongqing Zhuliu Bioengineering
    7.16.1. Company Overview
    7.16.2. Financial Highlights
    7.16.3. Product Portfolio
    7.16.4. SWOT Analysis
    7.16.5. Key Strategies and Developments
  - 7.17. Hunan Kingti Bio-Tech
    7.17.1. Company Overview
    7.17.2. Financial Highlights
    7.17.3. Product Portfolio
    7.17.4. SWOT Analysis
    7.17.5. Key Strategies and Developments
  - 7.18. ADM
    7.18.1. Company Overview
    7.18.2. Financial Highlights
    7.18.3. Product Portfolio
    7.18.4. SWOT Analysis
    7.18.5. Key Strategies and Developments
  - 7.19. Frutarom Health
    7.19.1. Company Overview
    7.19.2. Financial Highlights
    7.19.3. Product Portfolio
    7.19.4. SWOT Analysis
    7.19.5. Key Strategies and Developments
  - 7.20. Shaanxi Huike
    7.20.1. Company Overview
    7.20.2. Financial Highlights
    7.20.3. Product Portfolio
    7.20.4. SWOT Analysis
    7.20.5. Key Strategies and Developments
  - 7.21. Xi'an Desheng yuan
    7.21.1. Company Overview
    7.21.2. Financial Highlights
    7.21.3. Product Portfolio
    7.21.4. SWOT Analysis
    7.21.5. Key Strategies and Developments
  - 7.22. Jiangxi Shun Tiancheng
    7.22.1. Company Overview
    7.22.2. Financial Highlights
    7.22.3. Product Portfolio
    7.22.4. SWOT Analysis
    7.22.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Quercegen Pharmaceuticals
- Cayman Chemical Company
- Foodchem International Corporation
- Extrasynthese
- INDOFINE Chemical Company, Inc.
- Pharmachem Laboratories Inc.
- Organic Herb Inc.
- Toroma Organics Ltd
- Phytocompounds
- Indena S.p.A
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)